These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 21569922)
21. [Treatment of corneal ulcerations with use of the amniotic membrane]. Gierek-Łapińska A; Mrukwa-Kominek E; Rokita-Wala I; Gierek-Ciaciura S Klin Oczna; 2001; 103(2-3):95-100. PubMed ID: 11873419 [TBL] [Abstract][Full Text] [Related]
22. Amniotic membrane transplantation for corneal perforation related to vitamin A deficiency. Su WY; Chang SW; Huang SF Ophthalmic Surg Lasers Imaging; 2003; 34(2):140-4. PubMed ID: 12665231 [TBL] [Abstract][Full Text] [Related]
23. Management, clinical outcomes, and complications of shield ulcers in vernal keratoconjunctivitis. Reddy JC; Basu S; Saboo US; Murthy SI; Vaddavalli PK; Sangwan VS Am J Ophthalmol; 2013 Mar; 155(3):550-559.e1. PubMed ID: 23218707 [TBL] [Abstract][Full Text] [Related]
24. [Use of multilayer amniotic membrane as first therapy for penetrating corneal ulcers]. Müller M; Meltendorf C; Mirshahi A; Kohnen T Klin Monbl Augenheilkd; 2009 Aug; 226(8):640-4. PubMed ID: 19672808 [TBL] [Abstract][Full Text] [Related]
25. Corneal tattooing to mask subsequent opacification after amniotic membrane grafting for stromal corneal ulcer. Lee JE; Jun JB; Choi HY; Oum BS; Lee JS Acta Ophthalmol Scand; 2006 Oct; 84(5):696-8. PubMed ID: 16965504 [TBL] [Abstract][Full Text] [Related]
26. [Corneal neurotrophic ulcers--clinical and etiopathogenic aspects]. Damian C; Craitoiu S; Preda M; Manescu R; Irimia A; Marinescu F Oftalmologia; 2007; 51(4):65-8. PubMed ID: 18543677 [TBL] [Abstract][Full Text] [Related]
27. Superficial keratectomy and amniotic membrane patch in the treatment of corneal plaque of vernal keratoconjunctivitis. Pelegrin L; Gris O; Adán A; Plazas A Eur J Ophthalmol; 2008; 18(1):131-3. PubMed ID: 18203099 [TBL] [Abstract][Full Text] [Related]
28. [Amniotic membrane transplantation and high-dose systemic cyclosporin A (Sandimmun optoral) for Mooren's ulcer]. Spelsberg H; Sundmacher R Klin Monbl Augenheilkd; 2007 Feb; 224(2):135-9. PubMed ID: 17309011 [TBL] [Abstract][Full Text] [Related]
29. Blood components for topical use in tissue regeneration: evaluation of corneal lesions treated with platelet lysate and considerations on repair mechanisms. Geremicca W; Fonte C; Vecchio S Blood Transfus; 2010 Apr; 8(2):107-12. PubMed ID: 20383304 [TBL] [Abstract][Full Text] [Related]
30. Use of nerve growth factor to treat congenital neurotrophic corneal ulceration. Tan MH; Bryars J; Moore J Cornea; 2006 Apr; 25(3):352-5. PubMed ID: 16633039 [TBL] [Abstract][Full Text] [Related]
35. Eye platelet-rich plasma in the treatment of ocular surface disorders. Alio JL; Rodriguez AE; WróbelDudzińska D Curr Opin Ophthalmol; 2015 Jul; 26(4):325-32. PubMed ID: 26058033 [TBL] [Abstract][Full Text] [Related]
36. Amniotic membrane as a biologic pressure patch for treating epithelial ingrowth under a damaged laser in situ keratomileusis flap. Lee ES; Lee HK; Cristol SM; Kim SC; Lee MI; Seo KY; Kim EK J Cataract Refract Surg; 2006 Jan; 32(1):162-5. PubMed ID: 16516797 [TBL] [Abstract][Full Text] [Related]
37. [Conservative and surgical treatment of neurotrophic keratopathy]. Seitz B; Grüterich M; Cursiefen C; Kruse FE Ophthalmologe; 2005 Jan; 102(1):15-26. PubMed ID: 15622497 [TBL] [Abstract][Full Text] [Related]
38. Easy-to-prepare autologous platelet-rich plasma in the treatment of refractory corneal ulcers. Wu TE; Chen CJ; Hu CC; Cheng CK Taiwan J Ophthalmol; 2015; 5(3):132-135. PubMed ID: 29018685 [TBL] [Abstract][Full Text] [Related]
39. Multilayer amniotic membrane transplantation for bacterial keratitis with corneal perforation after hyperopic photorefractive keratectomy: case report and literature review. Nubile M; Carpineto P; Lanzini M; Ciancaglini M; Zuppardi E; Mastropasqua L J Cataract Refract Surg; 2007 Sep; 33(9):1636-40. PubMed ID: 17720083 [TBL] [Abstract][Full Text] [Related]
40. [Management of herpes zoster neurotrophic ulcer using a new matrix therapy agent (RGTA): A case report]. De Monchy I; Labbé A; Pogorzalek N; Gendron G; M'Garrech M; Kaswin G; Labetoulle M J Fr Ophtalmol; 2012 Mar; 35(3):187.e1-6. PubMed ID: 22015067 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]